Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Power Walking in Cardiac Patients Who Underwent Post-coronary Angioplasty (PowerWalk)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04610060
Recruitment Status : Completed
First Posted : October 30, 2020
Last Update Posted : November 3, 2020
Sponsor:
Information provided by (Responsible Party):
Gulf Medical University

Brief Summary:

The risk and prevalence of cardiovascular disease in United Arab Emirates (UAE) is high with ischemic heart disease ranks first in terms of major cause of mortality. Large number of patients undergoes coronary angioplasty but very few participate in cardiac rehabilitation because its awareness is not widespread in middle east region.

The objectives was to find the influence of standardized outpatient cardiac rehabilitation program along with power walking on Heart quality of life (Heart QoL), functional exercise capacity, Left Ventricular Ejection Fraction and metabolic equivalent task (MET's) among patients with post coronary angioplasty.

The investigators conducted a randomized clinical trail in out patient physiotherapy department at Thumbay hospitals Dubai, on patients who underwent coronary artery angioplasty. After meeting the inclusion criteria, participants were randomized into standardized outpatient cardiac rehabilitation program along with power walking (intervention group) or standardized outpatient cardiac rehabilitation program (control group).

A 4 weeks of 12 outpatient cardiac rehabilitation sessions consisting of 3 sessions per week was provided to both the groups. Intervention group received standardized outpatient cardiac rehabilitation program along with power walking based on targeted heart rate and weekly steps, whereas control group received only standardized outpatient cardiac rehabilitation program based on American College of Sports Medicine (ACSM) Guidelines.

The investigators measured Quality Of Life (HRQoL) by HeartQoL questionnaire, Exercise Capacity by 6 min walk test (6MWT), Left ventricle Ejection fraction (LVEF) using Echocardiogram, Metabolic Equivalent Task (MET'S) using Symptom-limited exercise stress test and Average number of steps walked daily using step up smartphone Pedometer App.


Condition or disease Intervention/treatment Phase
Heart Diseases, Ischemic Coronary Artery Disease Coronary Arteriosclerosis Coronary Syndrome Coronary Disease Behavioral: Power walking Behavioral: Standardised outpatient cardiac rehabilitation Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A 4-Week, Single-Blind, Parallel-Group Study
Masking: Double (Participant, Investigator)
Masking Description: For each participant were blinded till allocation of treatment. Investigator was also blinded.
Primary Purpose: Treatment
Official Title: Effectiveness of Standardized Outpatient Cardiac Rehabilitation Program Combined With Power Walking on Quality of Life and Exercise Capacity in Patients With Post-coronary Angioplasty: A Pragmatic Randomized Controlled Trial
Actual Study Start Date : April 7, 2020
Actual Primary Completion Date : September 10, 2020
Actual Study Completion Date : September 13, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Power walking group

Exercise in the form of Power walking at hospital for 10-20 minutes on treadmill with various exercise intensities. Weekly Steps at home 30 minutes walking with target to reach 1000 steps daily.

Standardised Outpatient Cardiac Rehabilitation based on ACSM Guidelines where provided for four weeks. The program consisted of warm up, aerobics, strengthening and cool down exercises based on ACSM Guidelines described in Table 1 (Deborah, Jonathan, Gary & Meir, 2018).

Behavioral: Power walking

Exercise in the form of Power walking at hospital for 10-20 minutes on treadmill with various exercise intensities. Weekly Steps at home 30 minutes walking with target to reach 1000 steps daily.

It is a form of exercise where active upper body movement is performed along with usual walking. It is a fast walking exercise done at a speed of 6 to 8 km/h. During power walking the back is kept straight with the centre of gravity moving from heal, sole, and to hallux. There is active swing back and forth movement of elbow joint with 90 degrees of flexion while walking.

Weekly protocol for power walking

  • Week 1 60-65 % of the target heart rate (THR) 5,000 to 7,499 steps/day
  • Week 2 65-70 % of the target heart rate (THR) 7,500 to 9,999 steps/day
  • Week 3 70-75 % of the target heart rate (THR) >=10,000 steps/day
  • Week 4 75-80 % of the target heart rate (THR) >12,500 steps per day

Behavioral: Standardised outpatient cardiac rehabilitation
Standardised Outpatient Cardiac Rehabilitation based on ACSM Guidelines the intervention group received the following four weeks of intense training program

Active Comparator: Standardised outpatient cardiac rehabilitation group
Standardised Outpatient Cardiac Rehabilitation based on ACSM Guidelines where provided for four weeks. The program consisted of warm up, aerobics, strengthening and cool down exercises based on ACSM Guidelines described in Table 1 (Deborah, Jonathan, Gary & Meir, 2018).
Behavioral: Standardised outpatient cardiac rehabilitation
Standardised Outpatient Cardiac Rehabilitation based on ACSM Guidelines the intervention group received the following four weeks of intense training program




Primary Outcome Measures :
  1. Heart Quality of Life questionnaire global scores [ Time Frame: From the start of treatment i.e., Day 1, Base line assessment until 4th week, i.e., completion of 12th therapy session ]
    HeartQoL questionnaire has 14-items with two subscales consisting of 10 and 4 -item of physical and emotional subscales respectively. Subscale scores are summarised to global scores. Standard deviation scores specific to population mean were used for statistical analysis.


Secondary Outcome Measures :
  1. Six Minute Walk Test (6MWT) distance in meters [ Time Frame: From the start of treatment i.e., Day 1, Base line assessment until 4th week, i.e., completion of 12th therapy session ]
    The outcome of the 6MWT is the 6-minute walk distance (6MWD) measured in meters.

  2. Percentage of Left ventricle Ejection fraction (LVEF) i.e., Percentage of blood pumped out of left ventricle during each contraction. [ Time Frame: From the start of treatment i.e., Day 1, Base line assessment until 4th week, i.e., completion of 12th therapy session ]
    Percentage of blood pumped out of left ventricle during each contraction measured by echocardiogram.

  3. Walking steps per day measured by pedometer [ Time Frame: From the start of treatment i.e., Day 1, Base line assessment until 4th week, i.e., completion of 12th therapy session ]
    A digital mobile application was used to record steps taken on day by day basis and cumulative average until 4th week was calculated

  4. Energy expenditure measured in Metabolic equivalent of task (MET) [ Time Frame: From the start of treatment i.e., Day 1, Base line assessment until 4th week, i.e., completion of 12th therapy session ]
    MET was calculated based on symptom-limited exercise stress test, i.e, Bruce protocol.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Those patients underwent coronary angioplasty and willing to participate
  • Age between 18-70 years.
  • Both the genders.
  • Patients who completed not < 2 week and not >12 weeks post hospital discharge.
  • Patients not limited to diabetes mellitus, controlled Hypertension, Hyperlipidemia and obese.
  • Availability of smart phone.

Exclusion Criteria:

  • Malignancy.
  • Neurological disorders.
  • Psychoneurotic disorders Causing deficit in functioning.
  • Significant valvular diseases.
  • Active pericarditis or myocarditis.
  • Patient with complications related to angioplasty procedure.
  • Severe orthostatic hypotension.
  • Severe obstructive airway disease or any other chronic pulmonary disorder.
  • Physically disabled patients.
  • All Musculoskeletal disorders affecting movement of bilateral upper and lower limbs while walking at a faster speed of 6 to 8 km/h (47)
  • Patients contraindicated for exercises testing and training.
  • Severe uncontrolled hypertension (Systolic Blood Pressure >180 mmHg and/or Diastolic Blood Pressure >100 mmHg).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04610060


Locations
Layout table for location information
United Arab Emirates
Gulf Medical University
Ajman, United Arab Emirates
Sponsors and Collaborators
Gulf Medical University
Investigators
Layout table for investigator information
Principal Investigator: Kumaraguruparan Gopal, Ph.D Gulf Medical University
Study Director: Ramprasad M, Ph.D Gulf Medical University
Layout table for additonal information
Responsible Party: Gulf Medical University
ClinicalTrials.gov Identifier: NCT04610060    
Other Study ID Numbers: INT/COHS/PG/015-2020
First Posted: October 30, 2020    Key Record Dates
Last Update Posted: November 3, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Gulf Medical University:
cardiac rehabilitation
coronary angioplasty
power walking
heart quality of life
metabolic equivalents task
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Arteriosclerosis
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases